Autoimmune diseases specialist Immunovant has announced changes to its leadership team and the expanded development of its ...

A new report highlights disparities in access to CAR T-cell therapies across Europe, with eligible patient treatment rates as ...

The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to ...

Cambridge, USA-based biotech Repertoire Immune Medicines today announced a collaboration and license agreement with Genentech ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...

German family-owned pharma major Boehringer Ingelheim and Dutch precision oncology company Tessellate Bio have entered into a ...

US pharma major Bristol Myers Squibb (NYSE: BMY) saw its shares fall 4% in after-hours trading on Tuesday, after it announced ...

French drug developer Innate Pharma’s (Euronext Paris: IPH) shares were up 5.6% at 1.81 euros in early trading after it ...

The Russian pharma trade group Innovative Pharma (Inpharma) has sent an official letter to the Ministry of Industry and Trade ...

US biotech major Regeneron Pharmaceuticals has announced a significant expansion of its manufacturing capacity through a new ...